With one third of American children overweight and 75 percent not getting enough daily exercise, Henkel, the company behind some of the nation’s leading brands, including Dial®, Purex®, Right Guard® and Soft Scrub®, is actively addressing this urgent health and fitness crisis facing our nation’s youth. In cooperation with Alliance for a Healthier Generation (AHG), Henkel today announced the launch of its annual Henkel Helps Get Kids Fit program in an effort to make a change and improve the quality of life of an entire generation. With schools facing budget cuts and limited resources across the country, the Henkel Helps Get Kids Fit program will award one deserving school with $25,000 to be used toward equipment and services to enhance their students’ health and fitness education.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57305-henkel-helps-get-kids-fit-alliance-for-a-healthier-generation
As part of their ongoing partnership to help Americans improve their health and curb the onset of chronic diseases like diabetes, CVS/pharmacy and the 50 Million Pound Challenge announced today the availability of the 32-page 50 Million Pound Challenge Guide in all CVS/pharmacy retail locations.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/43523/
Bad dietary habits and modern sedentary lifestyles have converged to create a worldwide epidemic that is constantly increasing: obesity (BMI > 30).
One billion adults around the world and twenty-two million children under the age of 5 are overweight.
Faced with this problem, LPG wanted to study the effect of LPG® mechano stimulation on fat cells to obtain proven results of the impact of Cellu M6® on localised areas of fat.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/lpg/50526/
The nation’s obesity numbers continue to climb, yet surprisingly many Americans are falling short on key nutrients that could put their health at risk.1,2,3 To address the obesity epidemic the nation faces – especially among children – the federal government released the 2010 Dietary Guidelines for Americans, research-based nutrition guidance that aims to “prevent and/or reduce overweight and obesity through improved eating and physical activity behaviors.”3
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nationaldairycouncil/47923/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
Eisai Inc. today announced the launch of a new national television advertising campaign for BELVIQ® (lorcaserin HCl) CIV, an FDA-approved prescription therapy for chronic weight management. The advertisement will air on numerous channels including Lifetime, Oxygen and AMC.
The spot illustrates the struggles many people face when they are trying to lose or control their weight. BELVIQ is presented as a targeted approach to weight loss, that, when combined with diet and increased activity, may help some patients lose weight and keep it off.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7161051-eisai-launches-national-television-campaign-belviq-lorcaserin-hcl-civ
ChildObesity180 today launched a new initiative, the Active Schools Acceleration Project (ASAP), in the continuing effort toward reversing the trend of childhood obesity. Because of their strong support for Let’s Move!, her initiative to solve the problem of childhood obesity within a generation, First Lady Michelle Obama encouraged participation in the competition with a new video message.
ASAP, in a commitment with The Partnership for a Healthier America (PHA), is conducting a national competition to identify and reward the most creative, impactful, and scalable school-based programs and technological innovations that promote physical activity for children. The contest will award a total of $500,000 in prizes, with individual awards of up to $100,000. In addition to monetary awards, top winners will advance to participate in funded pilot studies aimed at expanding both reach and impact.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54594-childobesity180-innovation-in-physical-activity-competition-for-let-s-move
Whether looking to get slimmer and leaner or healthier and stronger, it is now more rewarding than ever with ViSalus’ PROJECT 10 Challenge. Developed to recognize and motivate people to achieve their health goals, PROJECT 10™ will award $10,000 every week in 2014 to 10 people ($1,000 each) who lose 10 lbs. or add 10 lbs. of lean muscle during their Body by Vi Challenge™.
Beginning today, people can visit challenge.com to start their PROJECT 10 Challenge by choosing a category and uploading a video. Every Monday, ViSalus will reveal the 10 weekly winners, and for each 10 lbs. lost, the company will donate 30 Vi-Shape® Nutritional Shake meals to a child in need through their PROJECT 10™ Kids program. Representing an entire month of nutritious breakfast, lunch or snack options, the donation puts an at-risk or overweight child on the path to a healthier life.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63082-visalus-fitness-weight-loss-resolution-reward-win-1k-lose-10-lb
People who don’t have diabetes think that they are ok. But the way so many people eat, they put themselves at risk for this disease. Eating a diet high in processed foods, high sugar, and simple carbohydrates increase your chances of Type II Diabetes and especially if you are overweight. Other risk factors for Type II Diabetes are elevated triglyceride, low HDL, and high blood pressure.
